Nuheara Limited announced key Executive appointments and associated restructure of its senior executive team. These changes cement the Company's transformation over the past two years into a medical device manufacturer of world-first US FDA-cleared Over The Counter (OTC) Hearing Aids. A key part of this transformation has been the cornerstone investment by Realtek, now Nuheara's largest shareholder.

Underpinning this investment is Nuheara's technology and product development leadership position in the global hearing industry. Ivan Kelly as Chief Financial Officer (CFO). Ivan is a seasoned corporate finance executive with extensive finance and investor relations working experience across Europe, Australia and most recently in the US.